Envista Holdings (NVST) Total Non-Current Liabilities (2018 - 2026)

Envista Holdings (NVST) recorded quarterly Total Non-Current Liabilities of $2.3 billion in Q2 2026, down 3.08% quarter-over-quarter from $2.4 billion in Q4 2025, and up 2.38% on a YoY basis from $2.3 billion in Q2 2025.

Envista Holdings (NVST) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends

Envista Holdings' Total Non-Current Liabilities history runs 9 years deep, the most recent figure standing at $2.3 billion for Q2 2026.

  • In Q2 2026, Total Non-Current Liabilities rose 2.38% year-over-year to $2.3 billion; the TTM figure through Apr 2026 stood at $2.3 billion (up 2.38% YoY), while the FY2025 annual figure was $2.4 billion, up 5.95% from the prior year.
  • Total Non-Current Liabilities was $2.3 billion for Q2 2026 at Envista Holdings, down from $2.4 billion in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $6.6 billion in Q3 2022 to a low of $2.1 billion in Q2 2023.
  • Historically, Total Non-Current Liabilities has averaged $2.8 billion across 5 years, with a median of $2.3 billion in 2024.
  • The sharpest annual moves came in 2022 and 2023: Total Non-Current Liabilities surged 186.55% in 2022, then sank 65.97% in 2023.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $2.2 billion in 2022, then advanced by 2.69% to $2.3 billion in 2023, then decreased by 0.56% to $2.3 billion in 2024, then gained by 5.95% to $2.4 billion in 2025, then retreated by 3.08% to $2.3 billion in 2026.
  • The last three Total Non-Current Liabilities figures came in at $2.3 billion (Q2 2026), $2.4 billion (Q4 2025), and $2.4 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn 1.91 Bn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn 24.24 Bn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn 17.13 Bn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn 941.16 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn 1.03 Bn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn 8.65 Bn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn 3.98 Bn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn 2.10 Bn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn 12.54 Bn
10 Envista Holdings 4.06 Bn 2.98 Bn 390.10 Mn 2.34 Bn

Historic Data

Download Data
DateValue
Apr 3, 2026 2.34 Bn
Dec 31, 2025 2.41 Bn
Sep 26, 2025 2.38 Bn
Jun 27, 2025 2.35 Bn
Mar 28, 2025 2.28 Bn
Dec 31, 2024 2.28 Bn
Sep 27, 2024 2.29 Bn
Jun 28, 2024 2.31 Bn
Mar 29, 2024 2.28 Bn
Dec 31, 2023 2.29 Bn
Sep 29, 2023 2.24 Bn
Jun 30, 2023 2.14 Bn
Mar 31, 2023 2.14 Bn
Dec 31, 2022 2.23 Bn
Sep 30, 2022 6.58 Bn
Jul 1, 2022 6.26 Bn
Apr 1, 2022 2.25 Bn
Dec 31, 2021 2.62 Bn
Oct 1, 2021 2.30 Bn
Jul 2, 2021 6.07 Bn